{"title":"他克莫司治疗白癜风对局部趋化因子分泌的影响","authors":"Yongping Xu, Miao-ni Zhou, R. Jin, Wen Xu, A. Xu","doi":"10.3760/CMA.J.ISSN.1671-0290.2019.04.019","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the abnormalities of local chemokines in patients with vitiligo and to explore the effect of tacrolimus on the secretion of chemokines in keratinocytes. \n \n \nMethods \nBlister fluids of 50 patients with vitiligo were collected, including lesion areas and normal areas. Luminex was used to analyze the concentration of local chemokines in patients with vitiligo to determine whether the chemokines were closely related to vitiligo. The effect of tacrolimus on chemokine secretion of was analyzed by Western blot in HaCaT cells. \n \n \nResults \nBy Luminex analysis of blister fluid, it was found that CXCL9 and CXCL10 were significantly higher in the leukoplakia of vitiligo, and there was a significant difference, compared with the blister fluid in the normal site (P<0.01). IFN-γ significantly stimulated the keratinocyte cell line HaCat to express CXCL9 and CXCL10. After pretreatment of HaCaT cells with 20 mg tacrolimus, the expression of CXCL9 and CXCL10 was significantly decreased, compared with the blank control (P<0.01). \n \n \nConclusions \nThe leukoplakia chemokines CXCL9 and CXCL10 are highly expressed in vitiligo patients. The tacrolimus can significantly reduce the expression of CXCL9 and CXCL10 in keratinocytes under stress, and it therefore plays a therapeutic role in vitiligo. \n \n \nKey words: \nVitiligo; Tacrolimus; Chemokine CXCL9; Chemokine CXCL10; HaCaT cells","PeriodicalId":10094,"journal":{"name":"中华医学美学美容杂志","volume":"25 1","pages":"322-325"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of tacrolimus in treating vitiligo on the secretion of local chemokine\",\"authors\":\"Yongping Xu, Miao-ni Zhou, R. Jin, Wen Xu, A. Xu\",\"doi\":\"10.3760/CMA.J.ISSN.1671-0290.2019.04.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo analyze the abnormalities of local chemokines in patients with vitiligo and to explore the effect of tacrolimus on the secretion of chemokines in keratinocytes. \\n \\n \\nMethods \\nBlister fluids of 50 patients with vitiligo were collected, including lesion areas and normal areas. Luminex was used to analyze the concentration of local chemokines in patients with vitiligo to determine whether the chemokines were closely related to vitiligo. The effect of tacrolimus on chemokine secretion of was analyzed by Western blot in HaCaT cells. \\n \\n \\nResults \\nBy Luminex analysis of blister fluid, it was found that CXCL9 and CXCL10 were significantly higher in the leukoplakia of vitiligo, and there was a significant difference, compared with the blister fluid in the normal site (P<0.01). IFN-γ significantly stimulated the keratinocyte cell line HaCat to express CXCL9 and CXCL10. After pretreatment of HaCaT cells with 20 mg tacrolimus, the expression of CXCL9 and CXCL10 was significantly decreased, compared with the blank control (P<0.01). \\n \\n \\nConclusions \\nThe leukoplakia chemokines CXCL9 and CXCL10 are highly expressed in vitiligo patients. The tacrolimus can significantly reduce the expression of CXCL9 and CXCL10 in keratinocytes under stress, and it therefore plays a therapeutic role in vitiligo. \\n \\n \\nKey words: \\nVitiligo; Tacrolimus; Chemokine CXCL9; Chemokine CXCL10; HaCaT cells\",\"PeriodicalId\":10094,\"journal\":{\"name\":\"中华医学美学美容杂志\",\"volume\":\"25 1\",\"pages\":\"322-325\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华医学美学美容杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1671-0290.2019.04.019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华医学美学美容杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1671-0290.2019.04.019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effects of tacrolimus in treating vitiligo on the secretion of local chemokine
Objective
To analyze the abnormalities of local chemokines in patients with vitiligo and to explore the effect of tacrolimus on the secretion of chemokines in keratinocytes.
Methods
Blister fluids of 50 patients with vitiligo were collected, including lesion areas and normal areas. Luminex was used to analyze the concentration of local chemokines in patients with vitiligo to determine whether the chemokines were closely related to vitiligo. The effect of tacrolimus on chemokine secretion of was analyzed by Western blot in HaCaT cells.
Results
By Luminex analysis of blister fluid, it was found that CXCL9 and CXCL10 were significantly higher in the leukoplakia of vitiligo, and there was a significant difference, compared with the blister fluid in the normal site (P<0.01). IFN-γ significantly stimulated the keratinocyte cell line HaCat to express CXCL9 and CXCL10. After pretreatment of HaCaT cells with 20 mg tacrolimus, the expression of CXCL9 and CXCL10 was significantly decreased, compared with the blank control (P<0.01).
Conclusions
The leukoplakia chemokines CXCL9 and CXCL10 are highly expressed in vitiligo patients. The tacrolimus can significantly reduce the expression of CXCL9 and CXCL10 in keratinocytes under stress, and it therefore plays a therapeutic role in vitiligo.
Key words:
Vitiligo; Tacrolimus; Chemokine CXCL9; Chemokine CXCL10; HaCaT cells
期刊介绍:
"Chinese Journal of Medical Aesthetics and Cosmetology" is a high-end academic journal focusing on the basic theoretical research and clinical application of medical aesthetics and cosmetology. In March 2002, it was included in the statistical source journals of Chinese scientific and technological papers of the Ministry of Science and Technology, and has been included in the full-text retrieval system of "China Journal Network", "Chinese Academic Journals (CD-ROM Edition)" and "China Academic Journals Comprehensive Evaluation Database". Publishes research and applications in cosmetic surgery, cosmetic dermatology, cosmetic dentistry, cosmetic internal medicine, physical cosmetology, drug cosmetology, traditional Chinese medicine cosmetology and beauty care. Columns include: clinical treatises, experimental research, medical aesthetics, experience summaries, case reports, technological innovations, reviews, lectures, etc.